期刊文献+

重症监护室患者连续性肾脏替代治疗中应用不同缓冲液的利与弊 被引量:2

The benefit and disadvantage between different type buffer solution continuous renal replacement therapy in critical patients in ICU
下载PDF
导出
摘要 重症监护室(ICU)患者通常需行连续性肾脏替代治疗(CRRT)。CRRT过程中,不同类型的缓冲液可能对水电解质酸碱平衡及临床预后产生不同的影响。本文拟对乳酸盐、碳酸氢盐及枸橼酸缓冲液的利弊,在不同危重情形下如何选择这些缓冲液做一综述。 Critically ill patients usually require continuous renal replacement treatment( CRRT). Different type of buffer solution may have different influence on acid-base-electrolyte balance as well as clinical prognosis. We aimed to review the benefit and disadvantage of lactate,bicarbonate as well as citrate buffer solutions,and how to choose these buffer solutions in different critically ill patients.
作者 杨满 袁伟杰
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 北大核心 2015年第5期478-480,共3页 Chinese Journal of Nephrology,Dialysis & Transplantation
关键词 连续性肾脏替代治疗 重症监护室 缓冲液 continuous renal replacement treatment critically ill buffer solution
  • 相关文献

参考文献13

  • 1Tian JH, Ma B, Yang K, et al. Bicarbonate- versus lactate-buffered solutions for acute continuous haemodiafiltration or haemofiltration. Cochrane Database Syst Rev,2015,3:CD006819.
  • 2Phypers B, Pierce JT.Lactate physiology in health and disease. Contin Educ Anaesth Crit Care Pain,2006,6(3) :128-132.
  • 3Bellomo R.Bench-to-bedside review : lactate and the kidney. Crit Care, 2002,6(4) :322-326.
  • 4Bollmann MD, Reveily 3P, Tappy L, et al. Effect of bicarbonate and lactate buffer on glucose and lactate metabolism during hemodiaflltration in patients with multiple organ failure.Intensive Care Med,2004,30(6) :1103-1110.
  • 5Gunnerson K J, Saul M, He S, et al. Lactate versus non-lactate metabolic acidosis:a retrospective outcome evaluation of critically ill patients.Grit Care, 2006,10 ( 1 ) : R22.
  • 6Alivanis P, Giannikouris I, Paliuras C, et al. Metformin-associated lactic acidosis treated with continuous renal replacement therapy. Clin Ther,2006,28(3) :396-400.
  • 7Tan HK, Uchino S, Bellomo R. Electrolyte mass balance during CVVH :lactate vs. bicarbonate-buffered replacement fluids. Ren Fail, 2004,26(2) : 149-153.
  • 8Lanckohr C, Hahnenkamp K, Boschin M. Continuous renal replacement therapy with regional citrate anticoagulation:do we really know the details .9 Curr Opin Anaesthesiol, 2013,26 (4) : 428-437.
  • 9Mariano F, Morselli M, Bergamo D, et al.Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients. Nephrol Dial Transplant, 2011,26(12) :3882-3888.
  • 10Lameire N, Kellum JA ; KDIGO AKI Guideline Work Group.Contrast- induced acute kidney injury and renal support for acute kidney injury : a KDIGO summary (Part 2).Grit Care ,2013,17( 1 ) :205.

同被引文献14

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部